Issue 20, 2017

Novel valproic aminophenol amides with enhanced glial cell viability effect

Abstract

New valproic acid derivatives were synthesized by coupling valproyl chloride with ortho-aminophenols, resulting in seven N-(ortho-hydroxyphenyl)valproamides. These amides share similar structural characteristics and exhibit tuneable electronic and steric contributions either without particular substituents, or through the inclusion of electro-donating (–Me), electro-withdrawing (–NO2) or pi electro-donating/sigma electro-withdrawing (–Cl) substituents at the aromatic ring. The identity of such derivatives was evidenced through spectroscopic characterization using FTIR, 1H, 13C and HETCOR NMR, as well as by analyzing their melting points. In particular, for three derivatives it was feasible to determine their chemical structures in the crystal phase; all three behaved in a similar fashion and exhibited very similar conformations independent of the attached substituents. The base compound was found to exhibit 15.8 times more activity in C6 cells and 4.4 times more activity in U373 cells compared with VPA. In general, the parent compound, or those having –Me as a substituent, presented a greater effect on C6 cells than U373 cells. However, those with –NO2 and –Cl substituents, as well as VPA, required similar doses for the IC50 in both cell lines. Modification of the base compound with a –Me or –NO2 substituent increased the effect on cell viability to ca. 20 times that of VPA in both C6 and U373, indicating that a larger structure causes an important enhancement in the inhibition of cell viability. In both cell lines, –Cl containing derivatives were the most active compounds. For these derivatives, an activity increase of ca. 59 and 47 times that of VPA was observed for C6 and U373 cells, respectively. An important perspective is that VPA analogues possessing an aromatic ring with a –Cl substituent may become central structures in the search for more potent pharmaceutical prototypes.

Graphical abstract: Novel valproic aminophenol amides with enhanced glial cell viability effect

Supplementary files

Article information

Article type
Paper
Submitted
03 Jan 2017
Accepted
23 Jan 2017
First published
21 Feb 2017
This article is Open Access
Creative Commons BY-NC license

RSC Adv., 2017,7, 12391-12399

Novel valproic aminophenol amides with enhanced glial cell viability effect

A. Alpuche-García, X. Dávila-González, L. Arregui and H. I. Beltrán, RSC Adv., 2017, 7, 12391 DOI: 10.1039/C7RA00048K

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements